Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

In Reply.

Padrón L, Rezende-Filho J, Amim-Junior J, Sun SY, Cortés-Charry R, Maestá I, Elias KM, Horowitz NS, Braga A, Berkowitz RS.

Obstet Gynecol. 2018 Jul;132(1):218. doi: 10.1097/AOG.0000000000002720. No abstract available.

PMID:
29939922
2.

Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.

Azoulay D, Nasser R, Sharon R, Simanovich L, Akria L, Shaoul E, Horowitz NA.

Br J Haematol. 2018 Jun 25. doi: 10.1111/bjh.15428. [Epub ahead of print] No abstract available.

PMID:
29938784
3.

Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?

Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ Jr.

Gynecol Oncol. 2018 Aug;150(2):233-238. doi: 10.1016/j.ygyno.2018.06.015. Epub 2018 Jun 20.

PMID:
29933927
4.

The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.

Davis M, Strickland K, Easter SR, Worley M Jr, Feltmate C, Muto M, Horowitz N, Berkowitz R, Feldman S.

Gynecol Oncol. 2018 Jul;150(1):67-72. doi: 10.1016/j.ygyno.2018.05.002. Epub 2018 May 9.

PMID:
29751992
5.

Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).

Ditzel HM, Strickland KC, Meserve EE, Stover E, Konstantinopoulos PA, Matulonis UA, Muto MG, Liu JF, Feltmate C, Horowitz N, Berkowitz RS, Gupta M, Hecht JL, Lin DI, Jochumsen KM, Welch WR, Hirsch MS, Quade BJ, Lee KR, Crum CP, Mutter GL, Nucci MR, Howitt BE.

Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000513. [Epub ahead of print]

PMID:
29750700
6.

Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy.

Padrón L, Rezende Filho J, Amim Junior J, Sun SY, Charry RC, Maestá I, Elias KM, Horowitz N, Braga A, Berkowitz RS.

Obstet Gynecol. 2018 Apr;131(4):652-659. doi: 10.1097/AOG.0000000000002522.

PMID:
29528932
7.

Life cycle assessment of bottled water: A case study of Green2O products.

Horowitz N, Frago J, Mu D.

Waste Manag. 2018 Jun;76:734-743. doi: 10.1016/j.wasman.2018.02.043. Epub 2018 Mar 2.

PMID:
29503054
8.

Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.

Ringelstein-Harlev S, Avivi I, Fanadka M, Horowitz NA, Katz T.

Cancer Immunol Immunother. 2018 May;67(5):739-748. doi: 10.1007/s00262-018-2128-x. Epub 2018 Feb 15.

PMID:
29450641
9.

Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival.

Markt SC, Tang T, Cronin AM, Katz IT, Howitt BE, Horowitz NS, Lee LJ, Wright AA.

PLoS One. 2018 Feb 15;13(2):e0193047. doi: 10.1371/journal.pone.0193047. eCollection 2018.

10.

Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.

Foldi J, Mougalian S, Silber A, Lannin D, Killelea B, Chagpar A, Horowitz N, Frederick C, Rispoli L, Burrello T, Abu-Khalaf M, Sabbath K, Sanft T, Brandt DS, Hofstatter EW, Hatzis C, DiGiovanna MP, Pusztai L.

Breast Cancer Res Treat. 2018 Jun;169(2):333-340. doi: 10.1007/s10549-017-4653-2. Epub 2018 Feb 2.

PMID:
29396664
11.

Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know?

Nitecki R, Berkowitz RS, Elias KM, Goldstein DP, Horowitz NS.

Int J Gynecol Cancer. 2018 May;28(4):824-828. doi: 10.1097/IGC.0000000000001192.

PMID:
29324544
12.

Extramammary Paget Disease of the Vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation.

Nitecki R, Davis M, Watkins JC, Wu YE, Vitonis AF, Muto MG, Berkowitz RS, Horowitz NS, Feltmate CM.

Int J Gynecol Cancer. 2018 Mar;28(3):632-638. doi: 10.1097/IGC.0000000000001189.

PMID:
29324542
13.

Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?

Braga A, Campos V, Filho JR, Lin LH, Sun SY, de Souza CB, da Silva RCAF, Leal EAS, Silveira E, Maestá I, Madi JM, Uberti EH, Viggiano M, Elias KM, Horowitz N, Berkowitz RS.

Gynecol Oncol. 2018 Feb;148(2):239-246. doi: 10.1016/j.ygyno.2017.12.007. Epub 2017 Dec 13.

PMID:
29248195
14.
15.

Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.

Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang B, Krivak TC, Richard SD, Rodriguez N, Birrer MJ, Backes FJ, Geller MA, Quinn M, Goodheart MJ, Mutch DG, Kavanagh JJ, Maxwell GL, Bookman MA.

Gynecol Oncol. 2018 Feb;148(2):275-280. doi: 10.1016/j.ygyno.2017.11.018. Epub 2017 Nov 28.

16.

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.

Horowitz NS, Larry Maxwell G, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS, Gershenson D, Java JJ, Bookman MA.

Gynecol Oncol. 2018 Jan;148(1):49-55. doi: 10.1016/j.ygyno.2017.10.011. Epub 2017 Nov 23.

17.

Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.

Maestá I, Nitecki R, Horowitz NS, Goldstein DP, de Freitas Segalla Moreira M, Elias KM, Berkowitz RS.

Gynecol Oncol. 2018 Jan;148(1):161-167. doi: 10.1016/j.ygyno.2017.10.028. Epub 2017 Oct 29.

PMID:
29092742
18.

A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors.

Haggerty AF, Hagemann A, Barnett M, Thornquist M, Neuhouser ML, Horowitz N, Colditz GA, Sarwer DB, Ko EM, Allison KC.

Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S102-S108. doi: 10.1002/oby.22021.

PMID:
29086522
19.

Which patients should I transplant with acute lymphoblastic leukemia?

Inbar T, Rowe JM, Horowitz NA.

Best Pract Res Clin Haematol. 2017 Sep;30(3):249-260. doi: 10.1016/j.beha.2017.07.005. Epub 2017 Jul 13. Review.

PMID:
29050698
20.

Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.

Dzimitrowicz H, Mougalian S, Storms S, Hurd S, Chagpar AB, Killelea BK, Horowitz NR, Lannin DR, Harigopal M, Hofstatter E, DiGiovanna MP, Adelson KB, Silber A, Abu-Khalaf M, Chung G, Zaheer W, Abdelghany O, Hatzis C, Pusztai L, Sanft TB.

J Oncol Pract. 2017 Dec;13(12):e1012-e1020. doi: 10.1200/JOP.2017.022731. Epub 2017 Oct 19.

PMID:
29048991
21.

Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery.

Pepin K, Bregar A, Davis M, Melamed A, Hinchcliff E, Gockley A, Horowitz N, Del Carmen MG.

Gynecol Oncol. 2017 Dec;147(3):612-616. doi: 10.1016/j.ygyno.2017.09.028. Epub 2017 Oct 4.

PMID:
28988028
22.

Discussion of: "Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?"

Chagpar AB, Horowitz N, Sanft T, Wilson LD, Silber A, Killelea B, Moran MS, DiGiovanna MP, Hofstatter E, Chung G, Pusztai L, Lannin DR.

Am J Surg. 2017 Dec;214(6):1089-1090. doi: 10.1016/j.amjsurg.2017.09.025. Epub 2017 Sep 30. No abstract available.

PMID:
28987415
23.

Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?

Chagpar AB, Horowitz N, Sanft T, Wilson LD, Silber A, Killelea B, Moran MS, DiGiovanna MP, Hofstatter E, Chung G, Pusztai L, Lannin DR.

Am J Surg. 2017 Dec;214(6):1082-1088. doi: 10.1016/j.amjsurg.2017.07.036. Epub 2017 Sep 18.

PMID:
28939252
24.

Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?

Bentur OS, Gurion R, Gafter-Gvili A, Gatt M, Shvidel L, Horowitz NA, Ram R, Herishanu Y, Sarid N, Paltiel O, Ganzel C, Kreiniz N, Dally N, Gutwein O, Raanani P, Avivi I, Perry C.

Leuk Lymphoma. 2018 May;59(5):1163-1171. doi: 10.1080/10428194.2017.1375102. Epub 2017 Sep 13.

PMID:
28901817
25.

Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB).

Chiu AS, Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR.

Am J Surg. 2017 Nov;214(5):907-913. doi: 10.1016/j.amjsurg.2017.07.008. Epub 2017 Jul 18.

PMID:
28736057
26.

Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis.

Horowitz NA, Henig I, Henig O, Benyamini N, Vidal L, Avivi I.

Leuk Lymphoma. 2018 Mar;59(3):610-616. doi: 10.1080/10428194.2017.1347651. Epub 2017 Jul 13.

PMID:
28703077
27.

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.

Dann EJ, Bairey O, Bar-Shalom R, Mashiach T, Barzilai E, Kornberg A, Akria L, Tadmor T, Filanovsky K, Abadi U, Kagna O, Ruchlemer R, Abdah-Bortnyak R, Goldschmidt N, Epelbaum R, Horowitz NA, Lavie D, Ben-Yehuda D, Shpilberg O, Paltiel O.

Br J Haematol. 2017 Sep;178(5):709-718. doi: 10.1111/bjh.14734. Epub 2017 Jun 7.

PMID:
28589704
28.

Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience.

Berrocal J, Saperstein L, Grube B, Horowitz NR, Chagpar AB, Killelea BK, Lannin DR.

Surg Res Pract. 2017;2017:5924802. doi: 10.1155/2017/5924802. Epub 2017 Apr 13.

29.

Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study.

Meserve EEK, Mirkovic J, Conner JR, Yang E, Muto MG, Horowitz N, Strickland KC, Howitt BE, Crum CP.

Gynecol Oncol. 2017 Jul;146(1):69-73. doi: 10.1016/j.ygyno.2017.04.015. Epub 2017 May 4.

PMID:
28479065
30.

Published abstracts at international meetings often over- or underestimate the initial response rate.

Beyar-Katz O, Rowe JM, Townsend LE, Tallman MS, Hadomi R, Horowitz NA.

Blood. 2017 Apr 20;129(16):2326-2328. doi: 10.1182/blood-2017-01-763144. Epub 2017 Mar 6. No abstract available.

PMID:
28264800
31.

Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review.

Lin LH, Maestá I, Braga A, Sun SY, Fushida K, Francisco RPV, Elias KM, Horowitz N, Goldstein DP, Berkowitz RS.

Gynecol Oncol. 2017 Apr;145(1):88-95. doi: 10.1016/j.ygyno.2017.01.021. Epub 2017 Jan 26. Review.

PMID:
28132722
32.

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD.

Cancer. 2017 May 15;123(6):985-993. doi: 10.1002/cncr.30414. Epub 2016 Nov 16.

33.

Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer.

Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM.

Gynecol Oncol. 2017 Jan;144(1):136-139. doi: 10.1016/j.ygyno.2016.11.009. Epub 2016 Nov 8.

PMID:
27836203
34.

Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.

Watkins JC, Howitt BE, Horowitz NS, Ritterhouse LL, Dong F, MacConaill LE, Garcia E, Lindeman NI, Lee LJ, Berkowitz RS, Nucci MR, Crum CP.

Mod Pathol. 2017 Mar;30(3):448-458. doi: 10.1038/modpathol.2016.187. Epub 2016 Nov 11.

35.

Environmental and economic analysis of an in-vessel food waste composting system at Kean University in the U.S.

Mu D, Horowitz N, Casey M, Jones K.

Waste Manag. 2017 Jan;59:476-486. doi: 10.1016/j.wasman.2016.10.026. Epub 2016 Nov 2.

PMID:
27816469
36.

Management and outcome of cervical cancer diagnosed in pregnancy.

Bigelow CA, Horowitz NS, Goodman A, Growdon WB, Del Carmen M, Kaimal AJ.

Am J Obstet Gynecol. 2017 Mar;216(3):276.e1-276.e6. doi: 10.1016/j.ajog.2016.10.034. Epub 2016 Oct 31.

PMID:
27810552
37.

Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities.

Horowitz NS, Goldstein DP, Berkowitz RS.

Gynecol Oncol. 2017 Jan;144(1):208-214. doi: 10.1016/j.ygyno.2016.10.024. Epub 2016 Oct 24. Review.

PMID:
27789086
38.

Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011.

Killelea BK, Chagpar AB, Horowitz NR, Lannin DR.

Am J Surg. 2017 Feb;213(2):426-432. doi: 10.1016/j.amjsurg.2016.05.018. Epub 2016 Jul 21.

PMID:
27769548
39.
40.

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.

Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR.

Medicine (Baltimore). 2016 Aug;95(35):e4614. doi: 10.1097/MD.0000000000004614.

41.

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.

Watkins JC, Yang EJ, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS, Syngal S, Yurgelun MB, Chittenden A, Hornick JL, Crum CP, Sholl LM, Howitt BE.

Int J Gynecol Pathol. 2017 Mar;36(2):115-127. doi: 10.1097/PGP.0000000000000312.

PMID:
27556954
42.

Racial Differences in Utilization of Breast Conservation Surgery: Results from the National Cancer Data Base (NCDB).

Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR.

Ann Surg Oncol. 2016 Oct;23(10):3272-83. doi: 10.1245/s10434-016-5475-x. Epub 2016 Aug 8.

PMID:
27503494
43.

Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age.

Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, Berkowitz RS, Horowitz NS.

Gynecol Oncol. 2016 Oct;143(1):73-76. doi: 10.1016/j.ygyno.2016.07.117. Epub 2016 Jul 30.

PMID:
27486130
44.

Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks.

Horowitz NA, Lavi N, Nadir Y, Brenner B.

Thromb Haemost. 2016 Sep 27;116(4):613-7. doi: 10.1160/TH16-02-0099. Epub 2016 Jul 28.

PMID:
27465578
45.

Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases.

Berkowitz RS, Horowitz NS, Elias K, Goldstein DP.

J Reprod Med. 2016 May-Jun;61(5-6):185-6. No abstract available.

PMID:
27424355
46.

Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013.

Sun SY, Goldstein DP, Bernstein MR, Horowitz NS, Mattar R, Maestá I, Braga A, Berkowitz RS.

J Reprod Med. 2016 May-Jun;61(5-6):210-4.

PMID:
27424360
47.

Timing of Referral to the New England Trophoblastic Disease Center: Does Referral with Molar Pregnancy Versus Postmolar Gestational Trophoblastic Neoplasia Affect Outcomes?

Diver EJ, Horowitz NS, Goldstein DP, Bernstein M, Berkowitz RS, Growdon WB.

J Reprod Med. 2016 May-Jun;61(5-6):187-91.

PMID:
27424356
48.

Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis.

Naffaa ME, Rozin AP, Horowitz N, Ben-Itzhak O, Braun-Moscovici Y, Balbir-Gurman A.

Case Rep Rheumatol. 2016;2016:1041787. doi: 10.1155/2016/1041787. Epub 2016 May 18.

49.

Breast cancer biology varies by method of detection and may contribute to overdiagnosis.

Hayse B, Hooley RJ, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR.

Surgery. 2016 Aug;160(2):454-62. doi: 10.1016/j.surg.2016.03.031. Epub 2016 May 27.

PMID:
27241117
50.

Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM.

Cancer Prev Res (Phila). 2016 Sep;9(9):713-20. doi: 10.1158/1940-6207.CAPR-15-0384. Epub 2016 May 24. Review.

Supplemental Content

Loading ...
Support Center